Please use this identifier to cite or link to this item:
Title: Comparison of high-performance liquid chromatography and the Abbott fluorescent polarization radioimmunoassay in the measurement of methotrexate.
Austin Authors: Cosolo, W;Drummer, Olaf H;Christophidis, N
Affiliation: Clinical Pharmacology and Therapeutics Unit, Austin Hospital, Heidelberg, Australia
Issue Date: 29-Sep-1989
Publication information: Journal of Chromatography; 494(): 201-8
Abstract: A modified high-performance liquid chromatographic (HPLC) technique for the assay of methotrexate is described and compared to the Abbott Fluorescence Polarization Radioimmunoassay. The reproducibility (coefficient of variation) at low concentrations was similar for the two assays: 8.1 and 8.5% for the Abbott and HPLC assay, respectively. The limit of detection of the two assays was also similar at 0.01 microM. The correlation coefficient for Abbott versus HPLC was 0.9833 with a gradient of 0.9545. Aspirin was the only drug that interfered with HPLC. Methotrexate's metabolite 7-hydroxymethotrexate did not interfere with the Abbott assay. Plasma half-lives were similar to oncology patients in the two rheumatological patients studied. The 7-hydroxymethotrexate half-life was 15 h.
Gov't Doc #: 2584317
Journal: Journal of chromatography
Type: Journal Article
Subjects: Administration, Oral
Chromatography, High Pressure Liquid.methods
Drug Interactions
Fluorescence Polarization
Indomethacin.administration & dosage
Injections, Intravenous
Methotrexate.administration & dosage.analogs & derivatives.blood.pharmacokinetics
Reagent Kits, Diagnostic
Rheumatic Diseases.blood.drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 17, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.